STAT

SEPTEMBER 24, 2024

Then, in 2018, she finally found a drug that kept her ADHD in check.  STAT is co-publishing this article by Tradeoffs. Lisa Ann Trainor struggled to stay on top of schoolwork, hold a job or even perform basic tasks like laundry for six exhausting years.   Continue to STAT+ to read the full story…

Drug Pricing 345

Drug Pricing Drug Development 345

STAT

OCTOBER 25, 2023

Want to stay on top of the science and politics driving biotech today?    Sign up  to get our biotech newsletter in your inbox. Hello, everyone. Damian here with a look at biotech’s latest nadir, the virtues of Neanderthal DNA, and the sudden success of a decades-old idea in oncology. Read the rest…

Drug Pricing 175

Drug Pricing Drug Development 175

Express Pharma

SEPTEMBER 6, 2023

Not only will this precipitate into lower treatment costs and ensure equitable biopharma access for Indian patients, but could also peg Indian pharma companies to become global market leaders in the biosimilars segment and effect a major change in drug pricing standards. appeared first on Express Pharma.

Insurance Coverage and Processing 59

Insurance Coverage and Processing Biosimilars Generic Medicine Drug Pricing 59

STAT

JUNE 4, 2023

The world has changed since 2018 when the Biotechnology Innovation Organization last brought its annual road show to Boston, complete with entrepreneurial boot camps, beer-flowing receptions, and four days of nonstop networking.

Vaccines 232

Vaccines Drug Pricing Drug Development 232

Pharmaceutical Technology

SEPTEMBER 26, 2022

These highlight the parent company’s focus on innovative and high-value drug development. Innovative drug development can be costly and risky due to clinical trial attrition of unproven drugs, but can provide a high return on investment when successful. stake in their consumer healthcare joint venture for $13bn.

Biosimilars 64

Biosimilars Drug Development Vaccines Dosage 64

STAT

MARCH 5, 2025

Chronic diseases, such as diabetes, cancer, and cardiovascular disease, pose one of the most significant health threats to Americans today. The share of Americans with multiple chronic conditions increased from 21.8% in 2001 to 27.2% In 2022, these illnesses claimed the lives of 1.9 Read the rest…

Drug Development 231

Drug Development Diabetes Drug Pricing 231